JNBA Financial Advisors’s Zimmer Biomet ZBH Stock Holding History

JNBA Financial Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.4K	Sell	259 -21	-8%	-$1.93K	﹤0.01%	397
2025 Q4	$25.2K	Buy	280 +5	+2%	+$474	﹤0.01%	401
2025 Q3	$27.1K	Sell	275 -160	-37%	-$15.9K	﹤0.01%	378
2025 Q2	$39.7K	Hold	435	–	–	﹤0.01%	315
2025 Q1	$49.2K	Hold	435	–	–	0.01%	282
2024 Q4	$46K	Hold	435	–	–	﹤0.01%	291
2024 Q3	$47K	Hold	435	–	–	﹤0.01%	294
2024 Q2	$47.2K	Hold	435	–	–	0.01%	288
2024 Q1	$57.4K	Sell	435 -23	-5%	-$2.87K	0.01%	274
2023 Q4	$55.7K	Sell	458 -67	-13%	-$7.48K	0.01%	273
2023 Q3	$58.9K	Buy	525 +54	+11%	+$6.86K	0.01%	266
2023 Q2	$68.6K	Hold	471	–	–	0.01%	261
2023 Q1	$60.9K	Buy	471 +53	+13%	+$6.65K	0.01%	270
2022 Q4	$53.3K	Hold	418	–	–	0.01%	275
2022 Q3	$44K	Hold	418	–	–	0.01%	287
2022 Q2	$44K	Buy	418 +23	+6%	+$2.73K	0.01%	293
2022 Q1	$51K	Sell	395 -12	-3%	-$1.45K	0.01%	286
2021 Q4	$50K	Hold	407	–	–	0.01%	306
2021 Q3	$58K	Hold	407	–	–	0.01%	278
2021 Q2	$64K	Hold	407	–	–	0.01%	266
2021 Q1	$63K	Hold	407	–	–	0.01%	261
2020 Q4	$61K	Hold	407	–	–	0.01%	247
2020 Q3	$54K	Sell	407 -103	-20%	-$13.5K	0.01%	235
2020 Q2	$59K	Hold	510	–	–	0.01%	225
2020 Q1	$50K	Hold	510	–	–	0.01%	219
2019 Q4	$74K	Hold	510	–	–	0.01%	205
2019 Q3	$68K	Buy	510 +113	+28%	+$14.6K	0.01%	203
2019 Q2	$45K	Buy	397 +52	+15%	+$6.09K	0.01%	254
2019 Q1	$43K	Buy	345 +31	+10%	+$3.52K	0.01%	244
2018 Q4	$32K	Hold	314	–	–	0.01%	255
2018 Q3	$40K	Hold	314	–	–	0.02%	246
2018 Q2	$34K	Hold	314	–	–	0.01%	269
2018 Q1	$33K	Hold	314	–	–	0.01%	271
2017 Q4	$37K	Hold	314	–	–	0.01%	253
2017 Q3	$36K	Hold	314	–	–	0.01%	243
2017 Q2	$39K	Hold	314	–	–	0.01%	228
2017 Q1	$37K	Hold	314	–	–	0.01%	232
2016 Q4	$31K	Sell	314 -446	-59%	-$47.8K	0.01%	249
2016 Q3	$96K	Buy	760 +446	+142%	+$55.1K	0.01%	373
2016 Q2	$37K	Hold	314	–	–	0.01%	229
2016 Q1	$33K	Hold	314	–	–	0.01%	233
2015 Q4	$31K	Sell	314 -103	-25%	-$10.1K	0.01%	237
2015 Q3	$38K	Buy	417 +309	+286%	+$31K	0.02%	208
2015 Q2	$11K	Hold	108	–	–	﹤0.01%	346
2015 Q1	$12K	Hold	108	–	–	﹤0.01%	354
2014 Q4	$12K	Hold	108	–	–	﹤0.01%	346
2014 Q3	$11K	Buy	108 +16	+17%	+$1.57K	0.01%	359
2014 Q2	$9K	Buy	92 +76	+475%	+$7.42K	﹤0.01%	366
2014 Q1	$2K	Hold	16	–	–	﹤0.01%	441
2013 Q4	$1K	Buy	+16	New	+$1.39K	﹤0.01%	421

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JNBA Financial Advisors's ZBH Position: Q1 2026 in Review

JNBA Financial Advisors reduced its Zimmer Biomet (ZBH) stake by 7.5% in Q1 2026, selling an estimated $1.93K and leaving 259 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #397.

JNBA Financial Advisors first reported a position in ZBH in Q4 2013 and has held it in 50 quarters since. The position peaked at $96K in Q3 2016. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

JNBA Financial Advisors held 259 shares of Zimmer Biomet worth $23.4K as of Q1 2026.
JNBA Financial Advisors sold 21 Zimmer Biomet shares in Q1 2026, an estimated $1.93K.
Zimmer Biomet made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q1 2026, its #397 holding.
JNBA Financial Advisors first reported a position in Zimmer Biomet in Q4 2013 and has held it in 50 quarters since.
JNBA Financial Advisors's Zimmer Biomet position peaked at $96K in Q3 2016.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on JNBA Financial Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.